Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.

MLA

Nakaya, Yosuke, et al. “Successful Treatment of Proven Coronavirus Disease 2019-Associated Pulmonary Aspergillosis with Liposomal Amphotericin B in a Patient with Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.” Journal of Infection & Chemotherapy (Elsevier Inc.), vol. 29, no. 2, Feb. 2023, pp. 223–27. EBSCOhost, https://doi.org/10.1016/j.jiac.2022.10.020.

APA

Nakaya, Y., Nakashima, Y., Harada, N., Yamada, K., Makuuchi, Y., Kuno, M., Takakuwa, T., Okamura, H., Nanno, S., Nishimoto, M., Koh, H., Nakagama, Y., Kido, Y., Kanno, T., Suzuki, T., Nakamae, H., Kakeya, H., & Hino, M. (2023). Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Journal of Infection & Chemotherapy (Elsevier Inc.), 29(2), 223–227. https://doi.org/10.1016/j.jiac.2022.10.020

Chicago

Nakaya, Yosuke, Yasuhiro Nakashima, Naonori Harada, Koichi Yamada, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, et al. 2023. “Successful Treatment of Proven Coronavirus Disease 2019-Associated Pulmonary Aspergillosis with Liposomal Amphotericin B in a Patient with Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.” Journal of Infection & Chemotherapy (Elsevier Inc.) 29 (2): 223–27. doi:10.1016/j.jiac.2022.10.020.